Pages that link to "Q40737770"

The following pages link to Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. (Q40737770):

Displaying 37 items.

• HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism (Q27675409) (← links)
• Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides (Q28202956) (← links)
• Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization (Q33206148) (← links)
• Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses (Q33707475) (← links)
• Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence (Q33755350) (← links)
• A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. (Q33772095) (← links)
• I-Ag7 is subject to post-translational chaperoning by CLIP. (Q34013568) (← links)
• H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers (Q34151755) (← links)
• Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules (Q34893634) (← links)
• Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors (Q35071179) (← links)
• CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs (Q35762700) (← links)
• The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway (Q35785432) (← links)
• The expression of HLA-DO (H2-O) in B lymphocytes (Q35794597) (← links)
• The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules (Q35821240) (← links)
• Right place, right time, right peptide: DO keeps DM focused (Q36266508) (← links)
• pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity (Q36323798) (← links)
• Germinal-center organization and cellular dynamics (Q36459345) (← links)
• Ubiquitination of HLA-DO by MARCH family E3 ligases (Q36848435) (← links)
• Recent advances in antigen processing and presentation (Q36945533) (← links)
• Ubiquitin-mediated fluctuations in MHC class II facilitate efficient germinal center B cell responses (Q36949908) (← links)
• Class-switched anti-insulin antibodies originate from unconventional antigen presentation in multiple lymphoid sites (Q36949925) (← links)
• Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity (Q37202316) (← links)
• MHC class II antigen presentation by dendritic cells regulated through endosomal sorting (Q38167996) (← links)
• Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance (Q38175028) (← links)
• Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells (Q38198018) (← links)
• TLR agonists downregulate H2-O in CD8alpha- dendritic cells (Q38625770) (← links)
• The Other Function: Class II-Restricted Antigen Presentation by B Cells (Q39225428) (← links)
• HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition (Q39978081) (← links)
• Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob. (Q40081254) (← links)
• Sibling rivalry: competition between MHC class II family members inhibits immunity (Q44284098) (← links)
• Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta (Q82661832) (← links)
• Synergy between B cell receptor/antigen uptake and MHCII peptide editing relies on HLA-DO tuning (Q90288626) (← links)
• HLA-DO Modulates the Diversity of the MHC-II Self-peptidome (Q90681131) (← links)
• Dendritic Cells Internalize Staphylococcus aureus More Efficiently than Staphylococcus epidermidis, but Do Not Differ in Induction of Antigen-Specific T Cell Proliferation (Q92156736) (← links)
• Class II MHC antigen processing in immune tolerance and inflammation (Q93020630) (← links)
• High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma (Q93054495) (← links)
• Human Intestinal Enteroids Model MHC-II in the Gut Epithelium (Q93088320) (← links)